ArticleJACC. CardioOncology2022

A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?

Paaladinesh Thavendiranathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.